• It is used non-reinforced for
missile nose cones and
ablative (boiloff-cooled)
rocket motors. • In fiber form, it is used to reinforce plastics and metals (see
Carbon fiber and
Graphite-reinforced plastic). •
Pebble-bed nuclear reactors use a coating of pyrolytic carbon as a
neutron moderator for the individual pebbles. • Used to coat graphite cuvettes (tubes) in
graphite furnace atomic absorption furnaces to decrease heat stress, thus increasing cuvette lifetimes. • Pyrolytic carbon is used for several applications in electronic thermal management: thermal-interface material, heat spreaders (sheets) and
heat sinks (fins). • It is occasionally used to make
tobacco pipes. • It is used to fabricate grid structures in some high-power
vacuum tubes. • It is used as a
monochromator for neutron and X-ray scattering studies. • Prosthetic heart valves •
Radial head prosthesis • It is also used in automotive industries where a desired amount of friction is required between two components. •
Highly oriented pyrolytic graphite (HOPG) is used as the dispersive element in HOPG spectrometers, which are used for X-ray spectrometry. • It is used in personal protective gear.
Biomedical applications Because blood clots do not easily form on it, it is often advisable to line a blood-contacting
prosthesis with this material in order to reduce the risk of
thrombosis. For example, it finds use in
artificial hearts and
artificial heart valves.
Blood vessel stents, by contrast, are often lined with a polymer that has
heparin as a pendant group, relying on drug action to prevent clotting. This is at least partly because of pyrolytic carbon's
brittleness and the large amount of
permanent deformation, which a stent undergoes during expansion. Pyrolytic carbon is also in medical use to coat anatomically correct orthopedic implants, a.k.a.
replacement joints. In this application it is currently marketed under the name "PyroCarbon". These implants have been approved by the U.S.
Food and Drug Administration for use in the hand for metacarpophalangeal (knuckle) replacements. They are produced by two companies: Tornier (BioProfile) and Ascension Orthopedics. On September 23, 2011,
Integra LifeSciences acquired Ascension Orthopedics. The company's pyrolytic carbon implants have been used to treat patients with different forms of osteoarthritis. In January 2021, Integra LifeSciences sold its orthopedics company to
Smith+Nephew for $240 million. The FDA has also approved PyroCarbon interphalangeal joint replacements under the
Humanitarian Device Exemption. == Footnotes ==